Phosphoproteomics and lung cancer research

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 12287-12314

  López, Elena ^a   Cho, William C S ^b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Lung cancer; Mass spectrometry; Phosphoproteomics; Post translational modification; Signaling pathway

Indexed keywords

ADENYLATE KINASE; CHEMOKINE RECEPTOR CXCR4; GLOBOTRIAOSYLCERAMIDE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; SCAFFOLD PROTEIN; STROMAL CELL DERIVED FACTOR 1; METAL NANOPARTICLE; PHOSPHOPEPTIDE;

ANALYTIC METHOD; AQUA METHOD; CANCER RESEARCH; DISEASE ASSOCIATION; HUMAN; INTERMETHOD COMPARISON; ITRAQ METHOD; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STABLE ISOTOPE LABELING BY AMINO ACID IN CELL CULTURE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; PATHOLOGY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; ISOTOPE LABELING; LUNG NEOPLASMS; MASS SPECTROMETRY; METAL NANOPARTICLES; PHOSPHOPEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84867762292     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131012287     Document Type: Review

References (118)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Word, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Cho, W.C.; Yip, T.T.; Cheng, W.W.; Au, J.S. Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis. Br. J. Cancer 2010, 102, 1731-1735.
3. Cho, W.C. Proteomics and translational medicine: Molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome. Expert Rev. Proteomics 2011, 8, 1-4.
4. Tan, F.; Jiang, Y.; Sun, N.; Chen, Z.; Lv, Y.; Shao, K.; Li, N.; Qiu, B.; Gao, Y.; Li, B.; et al. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis. Mol. Cell Proteomics 2012, 11, doi:10.1074/mcp.M111.008821.
5. Wang, C.I.; Chien, K.Y.; Wang, C.L.; Liu, H.P.; Cheng, C.C.; Chang, Y.S.; Yu, J.S.; Yu, C.J. Quantitative proteomics reveals regulation of KPNA2 and its potential novel cargo proteins in non-small cell lung cancer. Mol. Cell Proteomics 2012, doi:10.1074/mcp.M111.016592.
6. Kettenbach, A.N.; Gerber, S.A. Rapid and reproducible single-stage phosphopeptide enrichment of complex peptide mixtures: Application to general and phosphotyrosine-specific phosphoproteomics experiments. Anal. Chem. 2011, 83, 7635-7644.
7. Wright, P.C.; Noirel, J.; Ow, S.Y.; Fazeli, A. A review of current proteomics technologies with a survey on their widespread use in reproductive biology investigations. Theriogenology 2012, 77, 738-765.
8. Zhong, Y.; Hyung, S.J.; Ruotolo, B.T. Ion mobility-mass spectrometry for structural proteomics. Expert Rev. Proteomics 2012, 9, 47-58.
9. Schirle, M.; Bantscheff, M.; Kuster, B. Mass spectrometry-based proteomics in preclinical drug discovery. Chem. Biol. 2012, 19, 72-84.
10. Bouwman, J.; Vogels, J.T.; Wopereis, S.; Rubingh, C.M.; Bijlsma, S.; van Ommen, B. Visualization and identification of health space, based on personalized molecular phenotype and treatment response to relevant underlying biological processes. BMC Med. Genomics 2012, 5, doi:10.1186/1755-8794-5-1.
11. Catusse, J.; Meinhard, J.; Job, C.; Strub, J.M.; Fischer, U.; Pestsova, E.; Westhoff, P.; van Dorsselaer, A.; Job, D. Proteomics reveals potential biomarkers of seed vigor in sugarbeet. Proteomics 2011, 11, 1569-1580.
12. López, E.; Wesselink, J.J.; López, I.; Mendieta, J.; Gómez-Puertas, P.; Muñoz, S.R. Technical phosphoproteomic and bioinformatic tools useful in cancer research. J. Clin. Bioinforma. 2011, 1, doi:10.1186/2043-9113-1-26.
13. López, E.; López, I.; Sequí, J.; Ferreira, A. Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by phosphoproteomic and bioinformatic tools. J. Clin. Bioinforma. 2011, 1, doi:10.1186/2043-9113-1-16.
14. López, E.; López, I.; Ferreira, A.; Sequí, J. Clinical and technical phosphoproteomic research. Proteome Sci. 2011, 9, doi:10.1186/1477-5956-9-27.
15. Lodish, H.; Berk, A.; Zipursky, S.L.; Matsudaira, P.; Baltimore, D.; Darnell, J. Company. Molecular Cell Biology, 4th ed.; W.H. Freeman: New York, NY, USA, 2002.
16. Stryer, L. Biochemistry, 4th ed.; W.H. Freeman: New York, NY, USA, 1995.
17. Bauer, U.T.; Daujat, S.; Nielsen, S.J.; Nightingale, K.; Kouzarides, T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002, 33, 39-44.
18. Huang, W.J.; Wang, Y.C.; Chao, S.W.; Yang, C.Y.; Chen, L.C.; Lin, M.H.; Hou, W.C.; Chen, M.Y.; Lee, T.L.; Yang, P.; et al. Synthesis and biological evaluation of ortho-Aryl N-Hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors. Chem Med Chem 2012, doi:10.1002/cmdc.201200300.
19. Song, J.S.; Kim, Y.S.; Kim, D.K.; Park, S.I.; Jang, S.J. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients. Pathol. Int. 2012, 62, 182-190.
20. Shah, A.; Singh, H.; Sachdev, V.; Lee, J.; Yotsukura, S.; Salgia, R.; Bharti, A. Differential serum level of specific haptoglobin isoforms in small cell lung cancer. Curr. Proteomics 2010, 7, 49-65.
21. Greulich, H.; Kaplan, B.; Mertins, P.; Chen, T.H.; Tanaka, K.E.; Yun, C.H.; Zhang, X.; Lee, S.H.; Cho, J.; Ambrogio, L.; et al. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc. Natl. Acad. Sci. USA. 2012, 109, 14476-14481.
22. Vasseur, J.A.; Goetz, J.A.; Alley, W.R., Jr.; Novotny, M.V. Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins. Glycobiology 2012, doi:10.1093/glycob/cws108.
23. Andreeva, A.V.; Kutuzov, M.A. Cadherin 13 in cancer. Genes Chromosomes Cancer 2010, 49, 775-790.
24. Scherf, D.B.; Sarkisyan, N.; Jacobsson, H.; Claus, R.; Bermejo, J.L.; Peil, B.; Gu, L.; Muley, T.; Meister, M.; Dienemann, H.; et al. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene 2012, doi:10.1038/onc.2012,344.
25. Takezawa, K.; Pirazzoli, V.; Arcila, M.E.; Nebhan, C.A.; Song, X.; de Stanchina, E.; Ohashi, K.; Janjigian, Y.Y.; Spitzler, P.J.; Melnick, M.A.; et al. HER2 amplification: A potential mechanism of acquired resistance to EGFR inhibition in EGFR mutant lung cancers that lack the second-site EGFR T790M mutation. Cancer Discov. 2012, doi:10.1158/2159-8290.
26. Neumann, H.; Hazen, J.L.; Weinstein, J.; Mehl, R.A.; Chin, J.W. Genetically encoding protein oxidative damage. J. Am. Chem. Soc. 2008, 130, 4028-4033.
27. Liu, Z.; Zanata, S.M.; Kim, J.; Peterson, M.A.; di Vizio, D.; Chirieac, L.R.; Pyne, S.; Agostini, M.; Freeman, M.R.; Loda, M. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene 2012, doi:10.1038/onc.2012.188.
28. Lopez, E.; Wang, X.; Madero, L. Functional phosphoproteomic mass spectrometry-based approaches. Clin. Transl. Med. 2012, 1, doi:10.1186/2001-1326-1-20.
29. Hubbard, M.J.; Cohen, P. On target with a new mechanism for the regulation of protein-phosphorylation trends. Biochem. Sci. 1993, 18, 172-177.
30. Lenaz, G.; Genova, M.L. Supramolecular organisation of the mitochondrial respiratory chain: A new challenge for the mechanism and control of oxidative phosphorylation. Adv. Exp. Med. Biol. 2012, 748, 107-144.
31. Mann, M.; Ong, S.E.; Grønborg, M.; Steen, H.; Jensen, O.N.; Pandey, A. Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol. 2002, 20, 261-268.
32. Mann, M.; Jensen, O.N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 2003, 21, 255-261.
33. Yarbro, J.W. Oncogenes and cancer suppressor genes. Semin. Oncol. Nurs. 1992, 8, 30-39.
34. Martin, K.K.; Pilkington, G.J. Nm23: An invasion suppressor gene in CNS tumours? Anticancer Res. 1998, 18, 919-926.
35. Senderowicz, A.M. Cell cycle modulators for the treatment of lung malignancies. Clin. Lung Cancer 2003, 5, 158-168.
36. Ha, G.H.; Baek, K.H.; Kim, H.S.; Jeong, S.J.; Kim, C.M.; McKeon, F.; Lee, C.W. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation. Cancer Res. 2007, 67, 7155-7164.
37. Reddy, E.P.; Korapati, A.; Chaturvedi, P.; Rane, S. IL-3 signaling and the role of Src kinases, JAKs and STATs: A covert liaison unveiled. Oncogene 2000, 19, 2532-2547.
38. Rane, S.G.; Reddy, E.P. JAKs, STATs and Src kinases in hematopoiesis. Oncogene 2002, 21, 3334-3358.
39. Ralph, S.J. An update on malignant melanoma vaccine research: Insights into mechanisms for improving the design and potency of melanoma therapeutic vaccines. Am. J. Clin. Dermatol. 2007, 8, 123-141.
40. Gaestel, M.; Mengel, A.; Bothe, U.; Asadullah, K. Protein kinases as small molecule inhibitor targets in inflammation. Curr. Med. Chem. 2007, 14, 2214-2234.
41. Giamas, G.; Stebbing, J.; Vorgias, C.E.; Knippschild, U. Protein kinases as targets for cancer treatment. Pharmacogenomics 2007, 8, 1005-1016.
42. Knowles, M.A. Novel therapeutic targets in bladder cancer: Mutation and expression of FGF receptors. Future Oncol. 2008, 4, 71-83.
43. Jensen, O.N. Modification-specific proteomics: Characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 2004, 8, 33-41.
44. Delom, F.; Chevet, E. Phosphoprotein analysis: From proteins to proteomes. Proteome Sci. 2006, 4, doi:10.1186/1477-5956-4-15.
45. Ficarro, S.B.; McCleland, M.L.; Stukenberg, P.T.; Burke, D.J.; Ross, M.M.; Shabanowitz, J.; Hunt, D.F.; White, F.M. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20, 301-305.
46. Gruhler, A.; Olsen, J.V.; Mohammed, S.; Mortensen, P.; Faergeman, N.J.; Mann, M.; Jensen, O.N. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell. Proteomics 2005, 4, 310-327.
47. Li, X.; Gerber, S.A.; Rudner, A.D.; Beausoleil, S.A.; Haas, W.; Villén, J.; Elias, J.E.; Gygi, S.P. Large-scale phosphorylation analysis of α-factor-arrested Saccharomyces cerevisiae. J. Proteome Res. 2007, 6, 1190-1197.
48. Larsen, M.R.; Thingholm, T.E.; Jensen, O.N.; Roepstorff, P.; Jorgensen, T.J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell Proteomics 2005, 4, 873-886.
49. Zhang, X.; Ye, J.; Jensen, O.N.; Roepstorff, P. Highly efficient phosphopeptide enrichment by calcium phosphate precipitation combined with subsequent IMAC enrichment. Mol. Cell. Proteomics 2007, 6, 2032-2042.
50. Thingholm, T.E.; Jensen, O.N.; Robinson, P.J.; Larsen, M.R. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 2008, 7, 661-671.
51. Kjeldsen, F.; Giessing, A.M.; Ingrell, C.R.; Jensen, O.N. Peptide sequencing and characterization of post-translational modifications by enhanced ion-charging and liquid chromatography electron-transfer dissociation tandem mass spectrometry. Anal. Chem. 2007, 79, 9243-9252.
52. Gafken, P.R.; Lampe, P.D. Methodologies for characterizing phosphoproteins by mass spectrometry. Cell Commun. Adhes. 2006, 13, 249-262.
53. Larsen, M.R.; Graham, M.E.; Robinson, P.J.; Roepstorff, P. Improved detection of hydrophilic phosphopeptides using graphite powder microcolumns and mass spectrometry: Evidence for in vivo doubly phosphorylated dynamin I and dynamin III. Mol. Cell. Proteomics 2004, 3, 456-465.
54. Gobom, J.; Nordhoff, E.; Mirgorodskaya, E.; Ekman, R.; Roepstorff, P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 1999, 34, 105-116.
55. Jensen, S.S.; Larsen, M.R. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun. Mass Spectrom. 2007, 21, 3635-3645.
56. Engholm-Keller, K.; Larsen, M.R. Titanium dioxide as chemo-affinity chromatographic sorbent of biomolecular compounds-Applications in acidic modification-specific proteomics. J. Proteomics 2011, 75, 317-328.
57. Thingholm, T.E.; Jensen, O.N.; Larsen, M.R. Analytical strategies for phosphoproteomics. Proteomics 2009, 9, 1451-1468.
58. Thingholm, T.E.; Jensen, O.N.; Larsen, M.R. Enrichment and separation of mono- and multiply phosphorylated peptides using sequential elution from IMAC prior to mass spectrometric analysis. Methods Mol. Biol. 2009, 527, 67-78.
59. Gruhler, A.; Schulze, W.X.; Matthiesen, R.; Mann, M.; Jensen, O.N. Stable isotope labeling of Arabidopsis thaliana cells and quantitative proteomics by mass spectrometry. Mol. Cell Proteomics 2005, 4, 1697-1709.
60. Ye, J.; Zhang, X.; Young, C.; Zhao, X.; Hao, Q.; Cheng, L.; Jensen, O.N. Optimized IMAC-IMAC protocol for phosphopeptide recovery from complex biological samples. J. Proteome Res. 2010, 9, 3561-3573.
61. Sugiyama, N.; Masuda, T.; Shinoda, K.; Nakamura, A.; Tomita, M.; Ishihama, Y. Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications. Mol. Cell. Proteomics 2007, 6, 1103-1109.
62. Gobom, J.; Mirgorodskaya, E.; Nordhoff, E.; Hojrup, P.; Roepstorff, P. Use of vapor-phase acid hydrolysis for mass spectrometric peptide mapping and protein identification. Anal. Chem. 1999, 71, 919-927.
63. Larsen, M.R.; Højrup, P.; Roepstorff, P. Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry. Mol. Cell. Proteomics 2005, 4, 107-119.
64. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
65. Larsen, M.R. Mass spectrometric characterization of posttranslationally modified proteins-phosphorylation. Methods Mol. Biol. 2004, 251, 245-262.
66. Song, C.; Ye, M.; Liu, Z.; Cheng, H.; Jiang, X.; Han, G.; Songyang, Z.; Tan, Y.; Wang, H.; Ren, J.; et al. Systematic analysis of protein phosphorylation networks from phosphoproteomic data. Mol. Cell. Proteomics 2012, doi:10.1074/mcp.M111.012625.
67. Han, G.; Ye, M.; Liu, H.; Song, C.; Sun, D.; Wu, Y.; Jiang, X.; Chen, R.; Wang, C.; Wang, L.; et al. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 2010, 31, 1080-1089.
68. Worthington, J.; Cutillas, P.R.; Timms, J.F. IMAC/TiO(2) enrich for peptide modifications other than phosphorylation: Implications for chromatographic choice and database searching in phosphoproteomics. Proteomics 2011, 11, 4583-4587.
69. Speicher, K.D.; Kolbas, O.; Harper, S.; Speicher, D.W. Systematic analysis of peptide recoveries from in-gel digestions for protein identifications in proteome studies. J. Biomol. Tech. 2000, 11, 74-86.
70. Corthals, G.L.; Wasinger, V.C.; Hochstrasser, D.F.; Sanchez, J.C. The dynamic range of protein expression: A challenge for proteomic research. Electrophoresis 2000, 21, 1104-1115.
71. Grønborg, M.; Kristiansen, T.Z.; Stensballe, A.; Andersen, J.S.; Ohara, O.; Mann, M.; Jensen, O.N.; Pandey, A. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol. Cell. Proteomics 2002, 1, 517-527.
72. Zhang, Z.Y. Functional studies of protein tyrosine phosphatases with chemical approaches. Biochim. Biophys. Acta 2005, 1754, 100-107.
73. Klumpp, S.; Krieglstein, J. Phosphorylation and dephosphorylation of histidine residues in proteins. Eur. J. Biochem. 2002, 269, 1067-1071.
74. Raggiaschi, R.; Gotta, S.; Terstappen, G.C. Phosphoproteome analysis. Biosci. Rep. 2005, 25, 33-44.
75. Karas, M.; Hillenkamp, F. Laser desorption ionization of proteins with molecular masses exceeding 10000 daltons. Anal. Chem. 1988, 60, 2299-2301.
76. Fenn, J.B.; Mann, M.; Meng, C.K.; Wong, S.F.; Whitehouse, C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246, 64-72.
77. Annan, R.S.; Carr, S.A. Phosphopeptide analysis by matrix-assisted laser desorption time-of-flight mass spectrometry. Anal. Chem. 1996, 68, 3413-3421.
78. Steen, H.; Kuster, B.; Mann, M. Quadrupole time-of-flight versus triple quadrupole mass spectrometry for the determination of phosphopeptides by precursor ion scanning. J. Mass Spectrom. 2001, 36, 782-790.
79. Cooper, H.J.; Håkansson, K.; Marshall, A.G. The role of electron capture dissociation in biomolecular analysis. Mass Spectrom. Rev. 2005, 24, 201-222.
80. Wu, S.L.; Hühmer, A.F.; Hao, Z.; Karger, B.L. On-line LC-MS approach combining collision-induced dissociation (CID), electron-transfer dissociation (ETD), and CID of an isolated charge-reduced species for the trace-level characterization of proteins with post-translational modifications. J. Proteome Res. 2007, 6, 4230-4244.
81. Manning, G.; Whyte, D.B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
82. Beausoleil, S.A.; Jedrychowski, M.; Schwartz, D.; Elias, J.E.; Villén, J.; Li, J.; Cohn, M.A.; Cantley, L.C.; Gygi, S.P. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 2004, 101, 12130-12135.
83. Biemann, K. Contribution of mass-spectrometry to peptide and protein-structure. Biomed. Environ. Mass Spectrom. 1988, 16, 99-111.
84. Roepstorff, P.; Fohlman, J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 1984, 11, doi:10.1002/bms.1200111109.
85. Ong, S.E.; Mann, M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252-262.
86. Ong, S.E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D.B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
87. Gruhler, S.; Kratchmarova, I. Stable isotope labeling by amino acids in cell culture (SILAC). Methods Mol. Biol. 2008, 424, 101-111.
88. Ballif, B.A.; Roux, P.P.; Gerber, S.A.; MacKeigan, J.P.; Blenis, J.; Gygi, S.P. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc. Natl. Acad. Sci. USA 2005, 102, 667-672.
89. Ross, P.L.; Huang, Y.N.; Marchese, J.N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
90. Sachon, E.; Mohammed, S.; Bache, N.; Jensen, O.N. Phosphopeptide quantitation using amine-reactive isobaric tagging reagents and tandem mass spectrometry: Application to proteins isolated by gel electrophoresis. Rapid Commun. Mass Spectrom. 2006, 20, 1127-1134.
91. Zhang, Z.Y. Mechanistic studies on protein tyrosine phosphatases. Prog. Nucleic Acid Res. Mol. Biol. 2003, 73, 171-220.
92. Huang, P.H.; Cavenee, W.K.; Furnari, F.B.; White, F.M. Uncovering therapeutic targets for glioblastoma: A systems biology approach. Cell Cycle 2007, 6, 2750-2754.
93. Kirkpatrick, D.S.; Gerber, S.A.; Gygi, S.P. The absolute quantification strategy: A general procedure for the quantification of proteins and post-translational modifications. Methods 2005, 35, 265-273.
94. Wang, G.; Wu, W.W.; Zeng, W.; Chou, C.L.; Shen, R.F. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes. J. Proteome Res. 2006, 5, 1214-1223.
95. Bailey, J.L.; Tardif, S.; Dubé, C.; Beaulieu, M.; Reyes-Moreno, C.; Lefièvre, L.; Leclerc, P. Use of phosphoproteomics to study tyrosine kinase activity in capacitating boar sperm. Kinase activity and capacitation. Theriogenology 2005, 63, 599-614.
96. Bridon, G.; Bonneil, E.; Muratore-Schroeder, T.; Caron-Lizotte, O.; Thibault, P. Improvement of phosphoproteome analyses using FAIMS and decision tree fragmentation. Application to the insulin signaling pathway in Drosophila melanogaster S2 cells. J. Proteome Res. 2012, 11, 927-940.
97. Masuda, T.; Sugiyama, N.; Tomita, M.; Ishihama, Y. Microscale phosphoproteome analysis of 10000 cells from human cancer cell lines. Anal. Chem. 2011, 83, 7698-7703.
98. Sudhir, P.R.; Chen, C.H.; Kumari, M.P.; Wang, M.J.; Tsou, C.C.; Sung, T.Y.; Chen, J.Y.; Chen, C.H. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells. Mol. Cell. Proteomics 2012, doi:10.1074/mcp.M112.020875.
99. Gámez-Pozo, A.; Sánchez-Navarro, I.; Calvo, E.; Díaz, E.; Miguel-Martín, M.; López, R.; Agulló, T.; Camafeita, E.; Espinosa, E.; López, J.A.; et al. Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches. Mol. Biosyst. 2011, 7, 2368-2374.
100. Pierobon, M.; Belluco, C.; Liotta, L.A.; Petricoin, E.F., III. Reverse phase protein microarrays for clinical applications. Methods Mol. Biol. 2011, 785, 3-12.
101. Courcelles, M.; Lemieux, S.; Voisin, L.; Meloche, S.; Thibault, P. ProteoConnections: A bioinformatics platform to facilitate proteome and phosphoproteome analyses. Proteomics 2011, 11, 2654-2671.
102. Wojcechowskyj, J.A.; Lee, J.Y.; Seeholzer, S.H.; Doms, R.W. Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. PLoS One 2011, 6, e24918.
103. Pan, C.; Olsen, J.V.; Daub, H.; Mann, M. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol. Cell. Proteomics 2009, 8, 2796-2808.
104. Li, J.; Rix, U.; Fang, B.; Bai, Y.; Edwards, A.; Colinge, J.; Bennett, K.L.; Gao, J.; Song, L.; Eschrich, S.; et al. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat. Chem. Biol. 2010, 6, 291-299.
105. Mueller, C.; Edmiston, K.H.; Carpenter, C.; Gaffney, E.; Ryan, C.; Ward, R.; White, S.; Memeo, L.; Colarossi, C.; Petricoin, E.F. III; et al. One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens. PLoS One 2011, 6, e23780.
106. Huang, P.H. Phosphoproteomic studies of receptor tyrosine kinases: Future perspectives. Mol. Biosyst. 2012, 8, 1100-1107.
107. Gámez-Pozo, A.; Sánchez-Navarro, I.; Calvo, E.; Agulló-Ortuño, M.T.; López-Vacas, R.; Díaz, E.; Camafeita, E.; Nistal, M.; Madero, R.; Espinosa, E.; et al. PTRF/cavin-1 and MIF proteins are identified as NSCLC biomarkers by label-free proteomics. PLoS One 2012, 7, e33752.
108. Nanjundan, M.; Byers, L.A.; Carey, M.S.; Siwak, D.R.; Raso, M.G.; Diao, L.; Wang, J.; Coombes, K.R.; Roth, J.A.; Mills, G.B.; et al. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence. J. Thorac. Oncol. 2010, 5, 1894-1904.
109. Jun, H.J.; Johnson, H.; Bronson, R.T.; de Feraudy, S.; White, F.; Charest, A. The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation. Cancer Res. 2012, 72, 3764-3774.
110. Huerta-Yepez, S.; Yoon, N.K.; Hernandez-Cueto, A.; Mah, V.; Rivera-Pazos, C.M.; Chatterjee, D.; Vega, M.I.; Maresh, E.L.; Horvath, S.; Chia, D.; et al. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer 2011, 11, 259.
111. Cho, W.C. Omics Approaches in Cancer Research. In An Omics Perspective on Cancer Research; Cho, W.C., Ed.; Springer: Heidelberg, Germany, 2010; pp. 1-9.
112. Harsha, H.C.; Pandey, A. Phosphoproteomics in cancer. Mol. Oncol. 2010, 4, 482-495.
113. Trost, M.; Bridon, G.; Desjardins, M.; Thibault, P. Subcellular phosphoproteomics. Mass Spectrom. Rev. 2010, 29, 962-990.
114. Zhou, H.; Albuquerque, C.P.; Liang, J.; Suhandynata, R.T.; Weng, S. Quantitative phosphoproteomics: New technologies and applications in the DNA damage response. Cell Cycle 2010, 9, 3479-3484.
115. Schaab, C. Analysis of phosphoproteomics data. Methods Mol. Biol. 2011, 696, 41-57.
116. López, E.; Muñoz, S.; Pascual, J.; Madero, L. Relevant phosphoproteomic and mass spectrometry: Approaches useful in clinical research. Clin. Transl. Med. 2012, doi:10.1186/2001-1326-1-2.
117. Lopez, E.; Madero, L.; Lopez-Pascual, J.; Latterich, M. Clinical proteomics and OMICS clues useful in translational medicine research. Proteome Sci. 2012, 10, doi:10.1186/1477-5956-10-35.
118. Cho, W.C.; Cheng, C.H. Oncoproteomics: Current trends and future perspectives. Expert Rev. Proteomics 2007, 4, 401-410.